Monopar Therapeutics Inc. Share Price Today, Forecast Target, Chat & Where To Buy [MNPR]

Home > Share Prices > Monopar Therapeutics Inc. share price (MNPR)

Today's Monopar Therapeutics Inc. share price is 99.35 (as of 12:19 09-Oct-2025) which is a change of 0.78 or 0.79% from the last closing price of 99.35 with 37,913 shares traded giving Monopar Therapeutics Inc. a market capitalisation of 647,083,182. The most recent daily high has been 100 and daily low 93.99. The Monopar Therapeutics Inc. share price 52 week high has been 105 and the 52 week low 4.5. Based on the most recent Monopar Therapeutics Inc. share price opening of 99.35, the current Monopar Therapeutics Inc. EPS (earnings per share) are -3.33 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Monopar Therapeutics Inc. Shares

It currently costs 99.35 to buy one share in Monopar Therapeutics Inc. (as of 12:19 09-Oct-2025) which is a change of 0.78 or 0.79% from the last closing price of 98.57. To buy shares in Monopar Therapeutics Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Monopar Therapeutics Inc. A Good Investment?

The below Monopar Therapeutics Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top